Advertisement

Ads Placeholder
Loading...

Structure Therapeutics Inc.

GPCR•NASDAQ
Healthcare
Biotechnology
$53.48
$3.31(6.60%)
U.S. Market opens in 27h 44m

Structure Therapeutics Inc. (GPCR) Stock Overview

Explore Structure Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.1B
P/E Ratio-22.42
EPS (TTM)$-2.40
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$47.69
3 Months$74.50
1 Year Target$44.15

GPCR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Structure Therapeutics Inc. (GPCR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $44.15.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.42 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
6.60%
5-Day Change
16.009%
1-Month Change
-15.16%
3-Month Change
-21.49%
6-Month Change
96.04%
Year-to-Date (YTD) Change
-21.49%
1-Year Change
227.50%
3-Year Change
104.51%
5-Year Change
105.69%
All-Time (Max) Change
105.69%

Contact Information

https://structuretx.com
628-229-9277
611 Gateway Boulevard, South San Francisco, CA, 94080

Company Facts

1,630 Employees
IPO DateFeb 3, 2023
CountryUS
Actively Trading

Frequently Asked Questions